Samuel C Leong1, Tristram H Lesser. 1. The Skull Base Unit, Department of Otorhinolaryngology-Head and Neck Surgery, University Hospital Aintree, Liverpool, U.K.
Abstract
OBJECTIVE: The aim of this survey was to objectively quantify the impact of facial palsy on the quality of life of acoustic neuroma patients. METHODS: The Facial Clinimetric Evaluation (FaCE) Scale was emailed to all members of the British Acoustic Neuroma Association (BANA). RESULTS: Of the 880 BANA members contacted, 398 (45.2%) responded, of which, 178 indicated that they had facial paralysis. Surgery for acoustic neuroma accounted for 80% of facial paralysis. Treatment received for facial palsy varied considerably, although 33% reported not receiving any treatment. The commonest single treatment modality wads facial electrical stimulation (41%), followed by facial physiotherapy (39%). The most common surgical procedures were to the eye lid (50%), followed by nerve graft (12%), forehead lift (10%), muscle sling (9%), and face lift (9%). The overall mean total FaCE Scale score was 54.8 (range, 10-100, standard deviation [SD] 21.2). Both facial movement and eye comfort domains had the lowest mean scores of 41.3 (SD, 29.9) and 41.2 (SD 32.6) respectively. The mean total FaCE Scale score of female respondents was statistically lower (p = 0.03) than males (52.6 (SD 21.2) versus 58.8 (SD 20.7) respectively), as were the difference in mean domain scores for facial comfort, eye comfort and social function. The mean total FaCE Scale scores of respondents aged below 40 years were the lowest. Younger patients had the lowest social function domain scores of all age groups. CONCLUSION: Facial paralysis is a significant problem in patients with acoustic neuroma. Based on this survey, treatment for facial paralysis is often not offered and even when given, still leaves the patient with a significantly lowered quality of life. However, it should be remembered that this study has surveyed a skewed patient population and that overall, most acoustic neuroma patients do not suffer with facial paralysis.
OBJECTIVE: The aim of this survey was to objectively quantify the impact of facial palsy on the quality of life of acoustic neuromapatients. METHODS: The Facial Clinimetric Evaluation (FaCE) Scale was emailed to all members of the British Acoustic Neuroma Association (BANA). RESULTS: Of the 880 BANA members contacted, 398 (45.2%) responded, of which, 178 indicated that they had facial paralysis. Surgery for acoustic neuroma accounted for 80% of facial paralysis. Treatment received for facial palsy varied considerably, although 33% reported not receiving any treatment. The commonest single treatment modality wads facial electrical stimulation (41%), followed by facial physiotherapy (39%). The most common surgical procedures were to the eye lid (50%), followed by nerve graft (12%), forehead lift (10%), muscle sling (9%), and face lift (9%). The overall mean total FaCE Scale score was 54.8 (range, 10-100, standard deviation [SD] 21.2). Both facial movement and eye comfort domains had the lowest mean scores of 41.3 (SD, 29.9) and 41.2 (SD 32.6) respectively. The mean total FaCE Scale score of female respondents was statistically lower (p = 0.03) than males (52.6 (SD 21.2) versus 58.8 (SD 20.7) respectively), as were the difference in mean domain scores for facial comfort, eye comfort and social function. The mean total FaCE Scale scores of respondents aged below 40 years were the lowest. Younger patients had the lowest social function domain scores of all age groups. CONCLUSION:Facial paralysis is a significant problem in patients with acoustic neuroma. Based on this survey, treatment for facial paralysis is often not offered and even when given, still leaves the patient with a significantly lowered quality of life. However, it should be remembered that this study has surveyed a skewed patient population and that overall, most acoustic neuromapatients do not suffer with facial paralysis.
Authors: James H Kim; Laurel M Fisher; Lindsay Reder; Edie R Hapner; Jon-Paul Pepper Journal: JAMA Otolaryngol Head Neck Surg Date: 2018-08-01 Impact factor: 6.223
Authors: Wouter L Lodder; Guleed H Adan; Chung S Chean; Tristram H Lesser; Samuel C Leong Journal: Eur Arch Otorhinolaryngol Date: 2017-04-08 Impact factor: 2.503
Authors: Anand V Kasbekar; Guleed H Adan; Alaina Beacall; Ahmed M Youssef; Catherine E Gilkes; Tristram H Lesser Journal: J Neurol Surg B Skull Base Date: 2017-11-08
Authors: Wouter L Lodder; Bernard F A M van der Laan; Tristram H Lesser; Samuel C Leong Journal: Eur Arch Otorhinolaryngol Date: 2018-01-12 Impact factor: 2.503
Authors: G Nina Lu; Mark R Villwock; Clinton D Humphrey; J David Kriet; Andrés M Bur Journal: JAMA Facial Plast Surg Date: 2019-01-01 Impact factor: 4.611
Authors: Giannicola Iannella; Marco de Vincentiis; Cira Di Gioia; Raffaella Carletti; Benedetta Pasquariello; Alessandra Manno; Diletta Angeletti; Ersilia Savastano; Giuseppe Magliulo Journal: J Int Med Res Date: 2017-04-27 Impact factor: 1.671